CPT code 88305: Surgical pathology Level IV billing guide

Key takeaways

CPT code 88305 reports Level IV surgical pathology, which covers routine biopsies needing both a gross and a microscopic examination.

The 2026 Medicare non-facility allowable computes to roughly $70-$73 nationally, before your locality’s geographic adjustment.

Level misassignment is the top denial trigger, and neighboring specimens like incidental appendix and testis biopsy are where it happens.

Seven documentation elements have to sit in the record before the claim goes out, from the requisition to the pathologist’s attestation.

Practice management software like Pabau checks the code and the documentation before the claim leaves the practice.

CPT code 88305 is the surgical pathology code for gross and microscopic examination at Level IV, per the AMA CPT code set. A licensed pathologist has to perform and document both the gross evaluation and the microscopic one.

The code sits inside the surgical pathology hierarchy that runs from 88302 to 88309, where the level reflects specimen complexity rather than the diagnosis. Level IV is the most commonly billed rung in outpatient and practice-based settings. It covers routine biopsies that need full histologic examination but stop short of the Level V and Level VI thresholds.

Specimens covered by CPT code 88305

The AMA parenthetical notes for 88305 define which specimen types qualify. Billing this code for a specimen that belongs to another level is upcoding or downcoding, and both carry compliance risk.

• Colon biopsy (including colorectal biopsy for polyp or inflammation workup)
• Cervix biopsy (cervical punch biopsy, colposcopy-directed biopsy)
• Endometrium curettings (D&C specimens, endometrial sampling)
• Prostate needle biopsy (systematic or targeted core biopsies)
• Skin, other than cyst/tag/debridement (punch biopsy, shave biopsy for lesion characterization)
• Bladder biopsy
• Bone marrow biopsy
• Breast biopsy (needle core or incisional, benign or pre-cancer workup)
• Lung, transbronchial biopsy
• Lymph node biopsy
• Nerve biopsy
• Sinus contents
• Synovium
• Testis, other than tumor, biopsy, or castration
• Thyroid, needle core biopsy

The same organ can appear on three different rungs of the ladder. What sets the level is the specimen submitted, not the anatomic site it came from.

A prostate TUR specimen bills under 88305, the same level as a prostate needle biopsy. A testis biopsy does not, because the AMA list puts it at Level V (88307).

Skin splits the same way, with a cyst, tag, or debridement at Level III (88304) and any other skin specimen at Level IV. Appendix runs lower still. An incidental appendix is Level II (88302), and only a non-incidental removal reaches 88304. The grid below sorts the specimens that land on the wrong rung most often.

Specimens outside the 88305 parenthetical list belong to a different pathology level. Review AAPC’s CPT code reference alongside the AMA codebook when you classify a specimen across the hierarchy.

What Medicare pays for 88305 in 2026

Medicare reimburses 88305 under the Physician Fee Schedule, at rates that vary by geographic locality and place of service. The 2026 non-facility national average works out to roughly $70-$73. That figure comes from the code’s 2.10 total RVUs multiplied by the CY2026 conversion factor of $33.4009.

Check your own MAC jurisdiction on the CMS Physician Fee Schedule lookup before you bill, because the rates change every January 1. For the underlying components, FastRVU’s 2026 RVU lookup shows work, practice expense, and malpractice RVUs with the geographic adjustment applied.

The non-facility rate consistently exceeds the facility rate, because independent labs carry the overhead a hospital absorbs. Commercial payer rates vary from Medicare, so verify the contracted rate with each one. Some payers pay a percentage of the Medicare allowable, and others use their own negotiated schedules. Medicaid rates, including Medi-Cal in California, usually sit below Medicare.

How to bill 88305 correctly

Four elements decide whether an 88305 claim pays cleanly. Work through them before you submit.

1. Verify the specimen qualifies as Level IV. Cross-reference the submitted specimen against the AMA parenthetical list for 88305. If it belongs to a different level, bill 88302, 88304, or 88307 accordingly. Level misassignment is the single most common 88305 denial trigger.
2. Apply the correct place of service (POS) code. POS 81 (independent laboratory) generates the non-facility rate. POS 22 (hospital outpatient) or POS 23 (emergency) generates the facility rate. The wrong POS code results in underpayment or denial.
3. Decide between global and split billing. If the pathologist performs both the professional (interpretation) and technical (lab processing) components, bill the global code with no modifier. If the components are split between providers, apply modifier -26 or -TC.
4. Confirm the ICD-10 medical necessity linkage. Every 88305 claim needs a diagnosis code that supports the reason for the biopsy. That code has to be specific to the specimen site and the clinical indication.

Modifiers that apply to 88305

ICD-10 codes that support medical necessity

Medical necessity for CPT code 88305 comes from the linked diagnosis code. It has to reflect the clinical reason for the biopsy, not the pathology finding that 88305 will establish.

When you look up ICD-10-CM codes for a pathology claim, work from the ordering clinician’s indication rather than the report’s conclusion. The pairings below are the highest-frequency ones across the primary specimen specialties.

Verify that the ordering clinician’s documentation supports the diagnosis code. A payer may deny 88305 if the linked ICD-10 code is absent from the Local Coverage Determination (LCD) for surgical pathology in your MAC jurisdiction.

88305 vs the other surgical pathology levels

Knowing where 88305 sits in the pathology hierarchy is what prevents level misassignment. The table below covers the full 88302 to 88309 spectrum plus the add-on codes that ride with it.

When 88341 or 88342 are billed with 88305, each immunohistochemistry stain needs its own documented medical necessity. The pathology report has to name the specific antibody used.

Why 88305 claims get denied

Denials on 88305 cluster into five patterns. Each one is preventable at the point the claim is built.

• Incorrect level assignment: Billing 88305 for a specimen that sits at another level. A skin tag belongs to Level III (88304), and a testis biopsy belongs to Level V (88307).
• Missing or incomplete clinical history: The requisition or electronic order does not carry the clinical indication for the biopsy. CMS requires it for the medical necessity determination.
• Specimen source not documented: The report or claim does not specify the anatomic site the specimen came from. “Tissue biopsy” is insufficient, while “transverse colon biopsy at 60 cm” is sufficient.
• ICD-10 mismatch: The linked diagnosis code is absent from the MAC’s LCD for 88305. It may also be a symptom code where a definitive diagnosis was available.
• Bundling without a modifier: Multiple specimens from different sites billed on the same date, with no modifier -59, where the payer’s bundling edits apply.

Progressive Corrective Action review and 88305

Progressive Corrective Action (PCA) is the medical review framework CMS sets out in its Program Integrity Manual. Medicare Administrative Contractors run it, escalating from provider education to prepayment review as an error rate climbs. Surgical pathology draws that attention because of its improper billing rates, and 88305 is the highest-volume code inside it.

Strong medical billing compliance is the defense against PCA scrutiny. A lab under prepayment review waits for Medicare to approve its documentation before payment releases, which can add weeks to the revenue cycle.

Documentation requirements for every 88305 claim

The checklist below reflects CMS and MAC LCD requirements for 88305. Each element has to be present in the medical record to support the claim.

• Requisition form: Completed by the ordering clinician with patient demographics, the clinical indication, and the specimen source.
• Clinical history: A brief narrative from the ordering provider explaining why the biopsy was performed. “Rule out malignancy” is acceptable. No history at all is not.
• Specimen source: The anatomic site, laterality where it applies, and the collection method (needle core, punch, excision).
• Gross examination: The pathologist’s description of the specimen’s size, color, and consistency before sectioning.
• Microscopic examination: The histologic findings described by the interpreting pathologist.
• Final diagnosis: A definitive pathologic diagnosis, or a qualified descriptive one such as “fragments of colonic mucosa with no diagnostic abnormality”.
• Pathologist attestation: The report identifies the pathologist who performed the examination and carries their electronic or wet signature.

Audit preparedness means all seven elements sit in every 88305 pathology report before the claim is submitted. Documentation added after a denial or an audit is generally not accepted as supporting evidence.

How Pabau keeps 88305 documentation and claims on one record

Most practices only catch a level error when the denial arrives. The requisition, the pathology report, and the claim sit in three separate systems, so the mismatch stays invisible until the remittance comes back.

Pabau’s medical claims management works from a single client record instead. The clinical indication is captured on a digital requisition form. The service and its code go onto the invoice, and the claim is built from the same file. Nobody re-keys a specimen source between systems, which is where the detail usually goes missing.

Routing the claim through a clearinghouse then adds a second check between the practice and the payer. Pabau connects to Claim.MD for that step, along with eligibility verification and electronic remittance advice. The scrub catches formatting errors, missing fields, and code combinations a payer will reject, before the claim reaches Medicare.

Stop 88305 denials before the claim goes out

Pabau keeps the requisition, the pathology documentation, and the claim on one client record, then scrubs it through the clearinghouse before submission. That means fewer missing fields and fewer resubmissions.

Book a demo

Conclusion

Level assignment is where 88305 revenue is won or lost. Get the specimen-to-level match right and check the seven documentation elements, and most denial and PCA exposure disappears before a claim is ever sent.

The trade-off is that the checking has to happen at order entry rather than at submission. A pathologist cannot go back and add a clinical history the ordering clinician never wrote. Book a demo to see how Pabau puts the code check and the documentation check in front of the claim instead of behind the denial.

Continue your research

Need to understand how claims move through the system? Medical claims clearinghouse overview explains how electronic claims reach payers and where validation errors occur.

Billing denials eating into pathology revenue? Denial codes in medical billing covers the most common CARC reason codes and how to respond to each one.

Want to understand revenue cycle management for your lab? Revenue cycle management fundamentals walks through the end-to-end billing lifecycle from patient registration to payment posting.

Frequently asked questions